Skip to main content

Peer Review reports

From: Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 months

Original Submission
12 Jan 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
22 Feb 2021 Reviewed Reviewer Report - Sami Hoque
23 Feb 2021 Reviewed Reviewer Report
21 Mar 2021 Author responded Author comments - Niels Teich
Resubmission - Version 4
21 Mar 2021 Submitted Manuscript version 4
Publishing
30 Mar 2021 Editorially accepted
12 Apr 2021 Article published 10.1186/s12876-021-01747-z

You can find further information about peer review here.

Back to article page